Cargando…

A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management

Glaucoma is a leading cause of preventable blindness globally. Nearly, half of the patients who have glaucoma in the United States are unaware of their diagnosis, and this number is far greater in resource poor areas. The risk of progressive and irreversible loss of vision is decreased with an early...

Descripción completa

Detalles Bibliográficos
Autores principales: Laroche, Daniel, Rickford, Kara, Mike, Elise V., Hunter, Liane, Ede, Ezekiel, Ng, Chester, Douglas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357680/
https://www.ncbi.nlm.nih.gov/pubmed/35957745
http://dx.doi.org/10.1155/2022/5288726
_version_ 1784763763290800128
author Laroche, Daniel
Rickford, Kara
Mike, Elise V.
Hunter, Liane
Ede, Ezekiel
Ng, Chester
Douglas, John
author_facet Laroche, Daniel
Rickford, Kara
Mike, Elise V.
Hunter, Liane
Ede, Ezekiel
Ng, Chester
Douglas, John
author_sort Laroche, Daniel
collection PubMed
description Glaucoma is a leading cause of preventable blindness globally. Nearly, half of the patients who have glaucoma in the United States are unaware of their diagnosis, and this number is far greater in resource poor areas. The risk of progressive and irreversible loss of vision is decreased with an early diagnosis, and better access to treatment is vital to improve the visual outcome for patients. We therefore postulated that a minimally invasive, low-cost calculator used to predict the risk of glaucoma and inform the course of follow-up care will improve patient prognosis. We retrospectively examined data from 104 eyes of patients who underwent a complete ocular examination, visual field, and corneal pachymetry at Advanced Eye Care of New York (54 with glaucoma and 50 controls). Receiver operating curves (ROC) were utilized to determine the correct glaucoma classification rates of the Laroche glaucoma calculator (Range −3 to 18), a novel tool that combines age, intraocular pressure (IOP), and central corneal thickness (CCT) into a composite metric. Additionally, we compared the discriminatory power of this calculator to age, intraocular pressure (IOP), and central corneal thickness (CCT) separately. A score of greater than or equal to 6 on the Laroche glaucoma calculator (sensitivity 90.74%, specificity 64.00%, correct classification 77.88%) optimizes the accuracy of this tool. Compared to IOP (Area Under the Curve (AUC) = 0.72, chi(2) = 4.21, p=0.04) and CCT (AUC = 0.53), chi(2) 24.72 p < 0.001), the Laroche glaucoma calculator (AUC = 0.81) was significantly better at discriminating against glaucoma patients vs. controls. These results demonstrate that the Laroche calculator is a novel, effective tool for identifying glaucoma, and it may provide a low-cost risk stratification tool, particularly in areas with limited resources.
format Online
Article
Text
id pubmed-9357680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93576802022-08-10 A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management Laroche, Daniel Rickford, Kara Mike, Elise V. Hunter, Liane Ede, Ezekiel Ng, Chester Douglas, John J Ophthalmol Research Article Glaucoma is a leading cause of preventable blindness globally. Nearly, half of the patients who have glaucoma in the United States are unaware of their diagnosis, and this number is far greater in resource poor areas. The risk of progressive and irreversible loss of vision is decreased with an early diagnosis, and better access to treatment is vital to improve the visual outcome for patients. We therefore postulated that a minimally invasive, low-cost calculator used to predict the risk of glaucoma and inform the course of follow-up care will improve patient prognosis. We retrospectively examined data from 104 eyes of patients who underwent a complete ocular examination, visual field, and corneal pachymetry at Advanced Eye Care of New York (54 with glaucoma and 50 controls). Receiver operating curves (ROC) were utilized to determine the correct glaucoma classification rates of the Laroche glaucoma calculator (Range −3 to 18), a novel tool that combines age, intraocular pressure (IOP), and central corneal thickness (CCT) into a composite metric. Additionally, we compared the discriminatory power of this calculator to age, intraocular pressure (IOP), and central corneal thickness (CCT) separately. A score of greater than or equal to 6 on the Laroche glaucoma calculator (sensitivity 90.74%, specificity 64.00%, correct classification 77.88%) optimizes the accuracy of this tool. Compared to IOP (Area Under the Curve (AUC) = 0.72, chi(2) = 4.21, p=0.04) and CCT (AUC = 0.53), chi(2) 24.72 p < 0.001), the Laroche glaucoma calculator (AUC = 0.81) was significantly better at discriminating against glaucoma patients vs. controls. These results demonstrate that the Laroche calculator is a novel, effective tool for identifying glaucoma, and it may provide a low-cost risk stratification tool, particularly in areas with limited resources. Hindawi 2022-07-31 /pmc/articles/PMC9357680/ /pubmed/35957745 http://dx.doi.org/10.1155/2022/5288726 Text en Copyright © 2022 Daniel Laroche et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Laroche, Daniel
Rickford, Kara
Mike, Elise V.
Hunter, Liane
Ede, Ezekiel
Ng, Chester
Douglas, John
A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title_full A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title_fullStr A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title_full_unstemmed A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title_short A Novel, Low-Cost Glaucoma Calculator to Identify Glaucoma Patients and Stratify Management
title_sort novel, low-cost glaucoma calculator to identify glaucoma patients and stratify management
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357680/
https://www.ncbi.nlm.nih.gov/pubmed/35957745
http://dx.doi.org/10.1155/2022/5288726
work_keys_str_mv AT larochedaniel anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT rickfordkara anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT mikeelisev anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT hunterliane anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT edeezekiel anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT ngchester anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT douglasjohn anovellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT larochedaniel novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT rickfordkara novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT mikeelisev novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT hunterliane novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT edeezekiel novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT ngchester novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement
AT douglasjohn novellowcostglaucomacalculatortoidentifyglaucomapatientsandstratifymanagement